Three reasons growth in the mammo systems market will likely slow
advertisement
Posição atual:
>
> This Story

starstarstarstarstar (3)
Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Women's Health Homepage

AI solution distinguishes complex pathologies for accurate breast cancer diagnosis Classify ductal carcinoma in situ from atypia

Dense breast laws not boosting ultrasound screening rates: study Researchers suggest risk of overdiagnosis may outweigh benefits in some cases

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

NY law requires coverage for medically necessary mammo for women under 40 More than 12,000 younger women diagnosed with breast cancer annually

Insights on implementing digital breast tomosynthesis from someone who knows As a radiologist launching her third DBT program at a breast imaging facility, Dr. Stacy Smith-Foley is uniquely poised to discuss its benefits

AI could enhance efficiency and accuracy of DBT, says study Can help reduce reading times for DBT

Study calls for greater discussion of cost in breast cancer surgery decisions Nearly one in three women consider cost when choosing breast cancer surgery procedures

The significance of the MQSA updates and ACP guidelines Setbacks and milestones for the breast imaging community

Improving care by enhancing fetal ultrasound imaging New tech is supporting better outcomes at NYU Winthrop

US Court of Appeals rejects Hologic petition to revisit patent invalidation Regards case against Minerva Surgical's Endometrial Ablation System

Three reasons growth in the mammo systems market will likely slow

By Imogen Fitt

When breast imaging comes to mind, mammography is the undisputed current modality of choice. Used as the primary screening tool for breast cancer, other breast imaging (BI) modalities, such as MR and ultrasound, form a comparatively smaller part of the market. For this reason, it is mammography that has typically driven the majority of BI’s market growth.

In our latest report, Signify Research has predicted that growth in the mammography market will begin to slow in the coming years. There are three key reasons why we see this occurring:
Story Continues Below Advertisement

Servicing GE, Philips and Siemens CT equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.


  • U.S. DBT installed based has started to saturate
  • Price pressure is set to increase
  • Interest and growth is expected to be driven from elsewhere

Each of these points are explored below:

1. U.S. DBT installed base has started to saturate
Over the last two years, the adoption of Digital Breast Tomosynthesis (DBT) technologies has seen the mammography market experience rapid growth. This trend has been particularly pronounced in the U.S., which peaked in 2017 after reimbursement had been introduced a few years earlier. There, providers spend upward of $300,000 on 3D solutions, compared to around $200,000 for their 2D counterparts.

The U.S. market is unique in that it formed over 55 percent of the global market in 2018, as Figure 1 shows. Providers in the U.S. are willing to invest in higher-cost solutions, resulting in higher average selling prices (ASP) that differ significantly from their European and Asian counterparts. It’s for this reason that growth in the U.S. market has a significant impact on worldwide growth.

And as the saying goes, "what goes up must eventually come down." Despite recording an increase in the installed base of systems for 2018, vendors have reported that growth in the U.S. market has begun to slow. As of June 2019, 61 percent of certified facilities possessed at least one DBT unit, and the market has now moved into late-stage adoption. Whilst the adoption of DBT is predicted to continue, albeit at a slower rate, the proportion of software upgrades as opposed to new system installs is expected to increase. Averaging at around $40,000-50,000 per software install, this gain in revenue will be significantly less compared to selling a whole new system.
  Pages: 1 - 2 - 3 - 4 >>

Women's Health Homepage


You Must Be Logged In To Post A Comment